These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3242762

  • 1. [Effects of thyroid-stimulating hormone on adenylate cyclase of well differentiated human carcinoma and adjacent normal tissues].
    Jap TS, Ho LT, Fan CH, Wu CW, Ching KN.
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):241-8. PubMed ID: 3242762
    [No Abstract] [Full Text] [Related]

  • 2. [Stimulation of adenyl cyclase and fixation of iodine in human cancerous thyroid cells in culture].
    Thomas-Morvan C.
    C R Acad Sci III; 1985 Oct; 301(10):487-90. PubMed ID: 3004675
    [Abstract] [Full Text] [Related]

  • 3. Adenyl cyclase hormone responses of certain human endocrine tumors.
    Schorr I, Hinshaw HT, Cooper MA, Mahaffee D, Ney RL.
    J Clin Endocrinol Metab; 1972 Mar; 34(3):447-51. PubMed ID: 4334767
    [No Abstract] [Full Text] [Related]

  • 4. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
    Siperstein AE, Miller RA, Clark OH.
    Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
    [Abstract] [Full Text] [Related]

  • 5. [Ultrastructural pathology and surgery of the thyroid gland].
    Seifert G.
    Dtsch Med Wochenschr; 1972 Sep 22; 97(38):1431-4. PubMed ID: 4627248
    [No Abstract] [Full Text] [Related]

  • 6. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
    Field JB, Bloom G, Chou MC, Kerins ME, Larsen PR, Kotani M, Kariya T, Dekker A.
    J Clin Endocrinol Metab; 1978 Nov 22; 47(5):1052-8. PubMed ID: 233688
    [Abstract] [Full Text] [Related]

  • 7. Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness.
    Siperstein AE, Zeng QH, Gum ET, Levin KE, Clark OH.
    World J Surg; 1988 Aug 22; 12(4):528-33. PubMed ID: 3420936
    [No Abstract] [Full Text] [Related]

  • 8. [Characterization of human thyroid adenyl cyclase].
    Jap TS, Ho LT, Wang HY, Wu CW, Ching KN.
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Aug 22; 40(2):201-10. PubMed ID: 3502835
    [No Abstract] [Full Text] [Related]

  • 9. Effects of antibodies to bovine thyroid plasma membranes on in vitro basal and thyroid-stimulating hormone stimulation of bovine thyroid adenylate cyclase.
    Mutoh H, Totsuka Y, Chou MC, Field JB.
    Endocrinology; 1980 Sep 22; 107(3):707-13. PubMed ID: 7190487
    [No Abstract] [Full Text] [Related]

  • 10. The adenylate cyclase-cyclic AMP-phosphodiesterase system in pathological human thyroid.
    Macchia V, Mandato E, Carella C, Pisano G, Biscaglia G.
    J Endocrinol Invest; 1978 Oct 22; 1(4):337-45. PubMed ID: 229151
    [Abstract] [Full Text] [Related]

  • 11. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y, Ichikawa Y, Muraki T, Ito K, Homma M.
    J Clin Endocrinol Metab; 1981 Jan 22; 52(1):23-8. PubMed ID: 6256403
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH, Gerend PL, Cote TC, Nissenson RA.
    Surgery; 1981 Aug 22; 90(2):252-61. PubMed ID: 6266060
    [Abstract] [Full Text] [Related]

  • 13. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
    Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C.
    Endocr Relat Cancer; 2010 Mar 22; 17(1):27-37. PubMed ID: 19779036
    [Abstract] [Full Text] [Related]

  • 14. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
    Mandato E, Meldolesi MF, Macchia V.
    Cancer Res; 1975 Nov 22; 35(11 Pt 1):3089-93. PubMed ID: 171062
    [Abstract] [Full Text] [Related]

  • 15. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.
    Carayon P, Thomas-Morvan C, Castanas E, Tubiana M.
    J Clin Endocrinol Metab; 1980 Oct 22; 51(4):915-20. PubMed ID: 7419673
    [Abstract] [Full Text] [Related]

  • 16. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE, Wahl RA, Branscheid D, Roeher HD.
    Surgery; 1984 Dec 22; 96(6):1001-8. PubMed ID: 6150553
    [Abstract] [Full Text] [Related]

  • 17. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR, Powel-Jones CH, Thomas CG, Nayfeh SN.
    Cancer Res; 1981 Jun 22; 41(6):2360-5. PubMed ID: 6263464
    [Abstract] [Full Text] [Related]

  • 18. Comparison of thyrotropin and sodium fluoride effects on thyroid adenyl cyclase.
    Burke G.
    Endocrinology; 1970 Feb 22; 86(2):346-52. PubMed ID: 5409933
    [No Abstract] [Full Text] [Related]

  • 19. [Morphological characteristics of the stroma of thyroid cancer].
    Dikshteĭn EA, Vecherko SE, Vasilenko IV, Shevchenko NI.
    Arkh Patol; 1985 Feb 22; 47(7):17-23. PubMed ID: 4051810
    [Abstract] [Full Text] [Related]

  • 20. Adenylate cyclase and protein phosphokinase activities in human thyroid. Comparison of normal glands, hyperfunctional nodules and carcinomas.
    Sand G, Jortay A, Pochet R, Dumont JE.
    Eur J Cancer (1965); 1976 Jun 22; 12(6):447-53. PubMed ID: 182442
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.